+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Melanoma"

Oncology. Edition No. 3. Lecture Notes - Product Thumbnail Image

Oncology. Edition No. 3. Lecture Notes

  • Book
  • January 2016
  • 368 Pages
Cellular Signalling in Cancer Metastasis - Product Thumbnail Image

Cellular Signalling in Cancer Metastasis

  • Book
  • August 2019
  • 300 Pages
Imaging in Dermatology - Product Thumbnail Image

Imaging in Dermatology

  • Book
  • August 2016
Outcome Prediction in Cancer - Product Thumbnail Image

Outcome Prediction in Cancer

  • Book
  • November 2006
Loading Indicator

Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease. The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market. Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more